Press Releases

08.31.2012

VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody

08.13.2012

Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium

08.09.2012

Nodality Enters into a Multi-Year Strategic Collaboration with Pfizer in Autoimmune Disease

07.11.2012

VERASTEM ACQUIRES CLINICAL-STAGE FAK INHIBITOR FROM PFIZER

04.23.2012

Quark Pharmaceuticals Announces Phase 2a Study of PF--04523655 (PF-655) in Patients with Moderate and Advanced OpenAngle Glaucoma (OAG

03.12.2012

Biocon And Pfizer Conclude Commercialization Agreement

02.17.2012

Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines

01.25.2012

KineMed announced a non-exclusive research collaboration with Pfizer for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.

01.10.2012

Ventana to collaborate with Pfizer and CST on companion diagnostic to identify lung cancer patients with ALK gene rearrangements

01.05.2012

PFIZER INITIATES PHASE 1 CLINICAL TRIAL FOR FVIIa HEMOPHILIA DRUG CANDIDATE DEVELOPED BY CATALYST BIOSCIENCES

12.25.2011

CollPlant to develop orthopedic product with Pfizer

12.24.2011

Karo Bio AB announced that it has entered into a research collaboration agreement with Pfizer to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.